P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia by B. Hajarizadeh, J. Grebely, G.V. Matthews, M. Martinello, G.J. Dore

Get full text

O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study by M. Alavi, J. Amin, J. Grebely, M.G. Law, N.Z. Janjua, M. Krajden, B. Hajarizadeh, J. George, G.V. Matthews, S. Larney, L. Degenhardt, G.J. Dore

Get full text

P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015 by S.R. Bartlett, T. Applegate, B. Jacka, F. Lamoury, R. Bull, M. Danta, D. Bradshaw, A.R. Lloyd, M. Hellard, G.J. Dore, G.V. Matthews, J. Grebely

Get full text

O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective by J.S. Doyle, A.L. Bowring, J. Cutts, J. Roney, D.M. Iser, J. Sasadeusz, M. O’Reilly, C. Fairley, E. Gane, J. Hoy, G.V. Matthews, N. Medland, R. Moore, M. Prins, M. Stoové, B.K. Tee, M.E. Hellard

Get full text

O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by J. Grebely, O. Dalgard, B. Conway, E. Cunningham, P. Bruggmann, B. Hajarizadeh, J. Amin, P. Marks, S. Quiene, T.L. Applegate, T. Swan, J. Byrne, M. Lacalamita, A. Dunlop, J. Bruneau, M.E. Hellard, G.V. Matthews, J. Powis, D. Shaw, M.C. Thurnheer, M. Weltman, I. Kronborg, C. Cooper, J.J. Feld, C. Fraser, A. Litwin, J. Dillon, P. Read, E. Gane, G.J. Dore

Get full text